NCT03237663View on ClinicalTrials.gov

Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules)

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 30, 2015

Primary Completion Date

November 5, 2016

Study Completion Date

June 23, 2017

Conditions
Safety of the Oral O1 / O139 Cholera Vaccine (Enteric Capsules)
Interventions
BIOLOGICAL

The oral O1 / O139 cholera vaccine (enteric capsules)

All Listed Sponsors
lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT03237663 - Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules) | Biotech Hunter | Biotech Hunter